Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS
Study Details
Study Description
Brief Summary
Correlation between intestinal parasites and serum level of eosinophils and IgE in individuals with HIV or aids attended at clinical hospital of the Botucatu Medical School-UNESP
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The present study correlates intestinal parasitism and levels of eosonophils and of serum IgEs in patients attended at the C.H. of the School of Medicine - Botucatu/UNESP. Thirty adult patients with AIDS were analyzed in the use of HAART, aged 42 ±11 years, 14 (46.7%) male, excluding those that had used anthelminthics 30 days prior to collection. Socioeconomic questionaires were applied and 3 samples of feces were taken for parasitological exams (TF-test® method) and 5 ml of blood for counting eosinophils (automated hematological counter, Pentra 80, ABX) and IgE doses (equipment BN-100, Dade-Behring). The index of parasites was 10%, with E.nana (3.3%), E.coli (3.3%) and B.hominis (3.3%). Parasitized individuals were from an urban region with complete basic sanitation and good socioeconomic level. Normal eosinphil values were found in all samples and increased IgE values in 1 (33.3%) sample. The index of parasites was low due to good socioeconomic level and disease control. Augmented IgE levels corroborate the literature, which reports an increase characteristic of immune response in the face of parasitic infections in individuals with HIV or AIDS. In conclusion, new studies should be undertaken to evaluate the level of eosinophils associated with cytokines to obtain a better understanding of this correlation.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
1 , 2 those with HIV |
Outcome Measures
Primary Outcome Measures
- all [one year]
Secondary Outcome Measures
- all [one year]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
HIV or AIDS
-
age same or superior to 18 years,
-
both sexes
-
assisted by the Hospital of the Clinics of Botucatu Medical School-UNESP
Exclusion Criteria:
-
use of anthelminthic in the period of 30 days antecedents the it dates from collection
-
individuals that don't have all of the necessary evaluations to the objectives of the study
-
individuals that abandon the attendance, or that you/they are to death during the study
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- UPECLIN HC FM Botucatu Unesp
Investigators
- Study Chair: Paulo C Pereira, Phd, Botucatu Medical School - UNESP
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- upeclin/HC/FMB-Unesp-02
- Botucatu Medical School UNESP